Clinical Trial Update: A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01) [Phase 3]

View source ↗

Summary

Phase 3 study updating BL-B01D1 vs physician's choice chemotherapy in recurrent or metastatic esophageal squamous cell carcinoma; the trial is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• BL-B01D1

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Esophageal Squamous Cell Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING